WallStreetZenWallStreetZen

NASDAQ: KYMR
Kymera Therapeutics Inc Stock Ownership - Who owns Kymera Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kymera Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Elena RidloffDirector2026-04-011,200$86.05
$103.26kSell
Jeremy G. ChadwickChief Operating Officer2026-04-0113,540$85.41
$1.16MSell
Jeremy G. ChadwickChief Operating Officer2026-04-011,100$86.05
$94.66kSell
Elena RidloffDirector2026-04-014,600$14.18
$65.23kBuy
Elena RidloffDirector2026-04-013,400$85.20
$289.66kSell
Jeremy G. ChadwickChief Operating Officer2026-04-0114,640$29.64
$433.93kBuy
Jeremy G. ChadwickChief Operating Officer2026-03-317,600$85.38
$648.88kSell
Jeremy G. ChadwickChief Operating Officer2026-03-317,600$29.64
$225.26kBuy
Elena RidloffDirector2026-03-317,400$14.18
$104.93kBuy
Elena RidloffDirector2026-03-317,400$85.37
$631.74kSell

1 of 14

KYMR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KYMR insiders and whales buy or sell their stock.

KYMR Shareholders

What type of owners hold Kymera Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC10.94%8,928,574$762.50MInstitution
Baker Bros Advisors LP10.60%8,657,242$739.33MInstitution
Baker Bros Advisors LP9.74%7,955,916$679.44MInsider
Avoro Capital Advisors LLC9.16%7,474,747$638.34MInstitution
Vanguard Group Inc7.68%6,267,644$535.26MInstitution
Price T Rowe Associates Inc7.54%6,159,335$526.01MInstitution
Atlas Venture Associates X LP7.06%5,763,012$492.16MInsider
Atlas Venture Fund X LP6.74%5,504,905$470.12MInsider
Bvf Inc6.74%5,502,710$469.93MInstitution
Blackrock Inc6.13%5,004,095$427.35MInstitution

1 of 3

KYMR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KYMR77.03%22.97%Net BuyingNet Selling
ACLX52.82%47.18%Net SellingNet Selling
BLTE18.27%1.13%
PTGX82.89%17.11%Net SellingNet Selling
IBRX16.47%7.45%Net BuyingNet Buying
View Top Biotech Stocks

Kymera Therapeutics Stock Ownership FAQ

Who owns Kymera Therapeutics?

Kymera Therapeutics (NASDAQ: KYMR) is owned by 110.07% institutional shareholders, 32.82% Kymera Therapeutics insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Kymera Therapeutics shareholder, owning 7.96M shares representing 9.74% of the company. Baker Bros Advisors LP's Kymera Therapeutics shares are currently valued at $679.44M.

If you're new to stock investing, here's how to buy Kymera Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.